glp-1 weight loss clinic wichita NEW ✨ Oral weight-loss option now available. We are now offering medical evaluations and prescriptions for FDA-approved oral semaglutide (Wegovy® tablet). A new option in GLP-1 weight-loss therapy — prescribed under Home - Wichita Medical Weightloss
Description
Symptoms include: Diarrhea (typically watery but not bloody) Low-grade fever Nausea Occasional muscle aches or headache Stomach cramps and pain Vomiting The vomiting and diarrhea are the largest concerns, as patients can quickly become dehydrated
[DOI] [PMC free article] [PubMed] [Google Scholar] 24.Nauck M.A., Quast D.R., Wefers J., Meier J.J
Chatterjee DJ, Khutoryansky N, Zdravkovic M, Sprenger CR, Litwin JS: Absence of QTc prolongation in a thorough QT study with subcutaneous liraglutide, a once-daily human GLP-1 analog for treatment of type 2 diabetes
The medication's known adverse effect profile, as detailed in the Summary of Product Characteristics (SmPC), does not specifically list changes in urine colour as a recognised occurrence
Confirmatory secondary endpoints evaluated the percentage change in body weight and a reduction in BMI of at least 5%
